Security key
03969F109
Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q2 2018 13F Holders as of 30 Jun 2018
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 22,392,855
- Total 13F value
- $274,091,081
- Share change
- +2,692,543
- SEC-reported price per share
- $12.24
- Number of holders
- 61
- Value change
- +$31,576,470
- Number of buys
- 39
- Number of sells
- 32
- Shares outstanding
- 122,470,452
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2018
Institutions
61
Top holders
10
RCUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2018
Previous quarter: Q1 2018
Arcus Biosciences, Inc. SEC filings
Arcus Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969F109
Recent filing periods:
Ownership snapshot
Top reported holders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alphabet Inc.
Disclosed value leader
Alphabet Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2018
13F
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
Alphabet Inc. leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alphabet Inc.'s linked filing trail.
Comparable ownership
Top 5
Alphabet Inc.
4.1%
Foresite Capital Management III, LLC
2.8%
EcoR1 Capital, LLC
1.8%
WELLINGTON MANAGEMENT GROUP LLP
1.7%
BVF INC/IL
1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alphabet Inc. |
13F
Company
|
4.1%
|
$77,969,000
5,049,786 shares
|
— | 31 Mar 2018 |
| Foresite Capital Management III, LLC |
13F
Company
|
2.8%
|
$42,080,000
3,445,461 shares
|
— | 31 Mar 2018 |
| EcoR1 Capital, LLC |
13F
Company
|
1.8%
|
$34,530,000
2,236,387 shares
|
— | 31 Mar 2018 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
1.7%
|
$32,216,000
2,116,945 shares
|
— | 31 Mar 2018 |
| BVF INC/IL |
13F
Company
|
1%
|
$19,606,000
1,269,788 shares
|
— | 31 Mar 2018 |
| PFM Health Sciences, LP |
13F
Company
|
0.76%
|
$14,410,000
933,286 shares
|
— | 31 Mar 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
61
Shares
22,392,855
Rows available
61
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
55
Q2 2018 holders
61
Holder diff
6
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 value | Q2 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend